Fortress Biotech (FBIO) News
NASDAQ: FBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.90+0.13 (+7.34%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
FBIO news summary
We found 5 recent headlines mentioning Fortress Biotech (FBIO): 0 in the past week and 5 in the past 30 days, most often from GlobeNewswire, Nasdaq. FBIO is making an outsized move today, up 7.34% at $1.90, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Fortress Biotech: 3 Key Takeaways for Long-Term Investors", was published by Nasdaq on Nov 13, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Fortress Biotech headlines
- Fortress Biotech: 3 Key Takeaways for Long-Term InvestorsKey PointsTotal revenue increased 8% to $19 million in the third quarter.Nasdaq
- Fortress Biotech (FBIO) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Fortress Biotech Reports Third Quarter 2026 Financial Results and Recent Corporate HighlightsTotal net revenue increased approximately 9% to $19.2 million for the third quarter of 2026 compared to the third quarter of 2025GlobeNewswire
- Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate HighlightsTotal revenues were $19.0 million for the third quarter of 2026GlobeNewswireDERM, FBIO
- Journey Medical Corporation to Announce Third Quarter 2026 Financial Results on November 12, 2026Company to host conference call to discuss financial results and provide a corporate update on November 12, 2026 at 4:30 p.m. ET Company to host conference call to discuss financial results and…GlobeNewswireDERM, FBIO